Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 61.45% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -7.15% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,178.57% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -1,480.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,480.00% |
| Dec 31, 2025 | -1,082.76% |
| Sep 30, 2025 | -393.33% |
| Jun 30, 2025 | -80.00% |
| Mar 31, 2025 | 71.01% |
| Dec 31, 2024 | 47.27% |
| Sep 30, 2024 | 82.56% |
| Jun 30, 2024 | -47.06% |
| Mar 31, 2024 | -72.50% |
| Dec 31, 2023 | -89.66% |
| Sep 30, 2023 | -258.33% |
| Jun 30, 2023 | 34.62% |
| Mar 31, 2023 | -33.33% |
| Dec 31, 2022 | -26.09% |
| Sep 30, 2022 | -9.09% |
| Jun 30, 2022 | -4.00% |
| Mar 31, 2022 | -11.11% |
| Dec 31, 2021 | 36.11% |
| Sep 30, 2021 | 29.03% |
| Jun 30, 2021 | 3.85% |
| Dec 31, 2020 | 18.18% |
| Sep 30, 2020 | 57.53% |
| Jun 30, 2020 | 62.32% |
| Dec 31, 2019 | -83.33% |
| Sep 30, 2019 | -21.67% |
| Jun 30, 2019 | -1.47% |
| Dec 31, 2018 | 32.28% |
| Sep 30, 2018 | -566.67% |
| Jun 30, 2018 | 53.42% |
| Dec 31, 2017 | 94.90% |
| Sep 30, 2017 | 97.21% |
| Jun 30, 2017 | 81.33% |
| Dec 31, 2016 | -1,187.04% |
| Sep 30, 2016 | -976.67% |
| Jun 30, 2016 | -2,269.70% |